Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Influenza virus infections affect millions of people annually, and current available vaccines provide varying rates of protection. However, the way in which the nasal microbiota, particularly established pneumococcal colonization, shape the response to influenza vaccination is not yet fully understood. In this study, we inoculated healthy adults with live Streptococcus pneumoniae and vaccinated them 3 days later with either tetravalent-inactivated influenza vaccine (TIV) or live attenuated influenza vaccine (LAIV). Vaccine-induced immune responses were assessed in nose, blood, and lung. Nasal pneumococcal colonization had no impact upon TIV-induced antibody responses to influenza, which manifested in all compartments. However, experimentally induced pneumococcal colonization dampened LAIV-mediated mucosal antibody responses, primarily IgA in the nose and IgG in the lung. Pulmonary influenza-specific cellular responses were more apparent in the LAIV group compared with either the TIV or an unvaccinated group. These results indicate that TIV and LAIV elicit differential immunity to adults and that LAIV immunogenicity is diminished by the nasal presence of S. pneumoniae. Therefore, nasopharyngeal pneumococcal colonization may affect LAIV efficacy.

Original publication

DOI

10.1172/jci.insight.141088

Type

Journal article

Journal

JCI Insight

Publication Date

22/02/2021

Volume

6

Keywords

Adaptive immunity, Immunology, Influenza, Vaccines, Adaptive Immunity, Adolescent, Adult, Antibodies, Viral, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Cytokines, Double-Blind Method, Female, Humans, Immunity, Mucosal, Immunoglobulin A, Influenza Vaccines, Influenza, Human, Lung, Male, Middle Aged, Nasopharynx, Orthomyxoviridae Infections, Pneumococcal Vaccines, Streptococcus pneumoniae, Vaccines, Attenuated, Young Adult